Scroll to Top
"Silo mindset in cost analysis" - Thomas Cueni - Basler Zeitung
16 September 2014
The global debate surrounding the cost of the new hepatitis C drug Sovaldi is symptomatic of the fact that the health policy debate is generally ...
Disappointing decision by the Indian Supreme Court to deny a first patent to Novartis’ break through medicine Glivec
09 April 2013
This week the Indian Supreme Court denied the patent application of Novartis for its breakthrough medicines Glivec even though it was rewarded a patent in ...
Upcoming Seventh International Pharmaceutical Compliance Congress - 21 - 23 May 2013 in Madrid (Spain)
22 February 2013
Visit the website for more information Register here Read the ...
Technology transfer to third countries: how to make it a win-win situation?
29 January 2013
On 22 January, MEP Christofer Fjellner hosted a lunch debate in the European Parliament on the transfer of technology from developed to developing countries. The aim was ...
23 October 2012
Introduction A clinical trial is a research study conducted in human participants to evaluate the safety and efficacy of a medicine expected to improve patients health. ...
Market Access Delays
06 August 2012
Patients' W.A.I.T. Indicator - Report 2011 The latest edition shows that, depending on the patients' country of residence, doctors would be able to prescribe between 23% ...
EMTRAIN on-course® promotion campaign launched!
25 June 2012
The efficient development, maintenance and sustainability of postgraduate ...
Coding & Identification of Products: towards safer medicines supply
23 June 2012
EFPIA is committed to securing the supply chain against counterfeit medicines. EFPIA is actively developing a coding solution that will enable medicine packs to be ...
EFPIA - College of Europe Awards
21 June 2012
Created in 2001, the EFPIA College of Europe Award is designed to support students presenting a Master’s Thesis in an area of particular interest to ...
07 June 2012
Leaders of industry have asked that EFPIA coordinate monitoring of European events, by setting up an on-line platform including pre-assessment reports of events sponsored by industry ...
Page 1 of 2
Reports & Studies
Facts & Figures
Follow us on
Add us on
Check us out on
EFPIA Brussels Office
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
European Biopharmaceutical Enterprises
INNOVATIVE MEDICINES INITIATIVE
Educational Events & Ethical Evaluation
EFPIA 2017 - All rights reserved -
- Design by
Morris & Chapman